MoneyWorks4Me

Procter & Gamble Health informs about change in senior management personnel

07 Dec 2024 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirement) Regulations, 2015, Procter & Gamble Health has informed that Ketan Kotadiya, shall cease to be Regulatory Affairs leader, effective December 6, 2024, due a change in his assignment at P&G. A copy of letter from Ketan Kotadiya is enclosed. Further, Nidhi Shroff will take over as Regulatory Affairs leader effective December 7, 2024. A brief profile of Shroff is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..